Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell|August 19, 2007
A new mutational AKTivation in the PI3K pathwayJoan Brugge, Mien-Chie Hung, Gordon B Mills
Research Square|July 1, 2024
Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsivenessJoan Brugge, Kung-Chi Chang, Francesca Silvestri, et al.
Bioengineering & Translational Medicine|March 17, 2023
Synergistic combination therapy delivered via layer-by-layer nanoparticles induces solid tumor regression of ovarian cancerStephanie Kong, Pearl Moharil, Abram Handly-Santana, et al.
Chemistry & Biology|March 27, 2010
A structure-guided approach to creating covalent FGFR inhibitorsWenjun Zhou, Wooyoung Hur, Ultan McDermott, et al.
The Journal of Experimental Medicine|November 19, 2003
Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cellsKeiko Fujikawa, Ana V Miletic, Frederick W Alt, et al.
Science Translational Medicine|June 2, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancersChaoyang Sun, Yong Fang, Jun Yin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-XL degradation to overcome cancer chemoresistanceXingping Qin, Adam Presser, Lissah Johnson, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancerMarc J Williams, Michael Uj Oliphant, Vinci Au, et al.
Cancer Cell|June 15, 2004
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifenXiao-Jun Ma, Zuncai Wang, Paula D Ryan, et al.
Pageof 1